Abstract
AbstractLipid vesicles may be safely and efficiently loaded with therapeutic dose levels of the beta emitter yttrium-90 (90Y) by using the ability of the cation ionophore A23187 to transport yttrium across the lipid bilayer where it is chelated on the vesicle interior by diethylenetriamine pentaacetic acid (DTPA). For 100 nm diameter vesicles composed of diplamitoylphosphatidylcholine (DPPC) and cholesterol (Choi), DPPC/Chol (1:1), containing 15 mM DTPA with 40 nmoles of external yttrium, total uptake was > 95% of added yttrium within 5 min at 50° using 0.4 ng of ionophore per nmole of lipid. Background binding in these neutral vesicles accounts for less than 0.1% of the yttrium associated with the vesicles. Important operational parameters were the amount of ionophore (> 0.2 μg of ionophore per μmole of lipid was required) and also the temperature (for DPPC/Chol (1:1) vesicles uptake at 40° was essentially background but was > 95% at 50°). The presence of the polymer polyethylene glycol (PEG) on the memb...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
